Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

Intervalo de año de publicación
1.
Plants (Basel) ; 11(20)2022 Oct 13.
Artículo en Inglés | MEDLINE | ID: mdl-36297725

RESUMEN

Curcuma longa (C. longa), an herbaceous plant used for medicinal purposes by the indigenous people of Easter Island, has been overexploited in its natural habitat, leading to its conservation status being designated as a vulnerable species. We have recently reported on the use of light-emitting diodes (LEDs) to improve the productivity of C. longa in vitro cultures under a temporary immersion system (TIS), but the effects of light quality on plant growth, phytochemical composition, and antioxidant capacity remained unexplored. Here, we set out to study these three aspects as observed at the end of TIS culture (day 0) and after 30 days of greenhouse acclimation (day 30). Thus, we evaluated plant morphological characteristics, phytochemical profile (polyphenols, tannins, flavonoids, reducing sugars, and curcumin), and radical scavenging activity by DPPH, ORAC, and FRAP assays. The results showed that, during in vitro cultivation under TIS, the red:blue (RB) LED light spectrum promoted C. longa shoot proliferation, with the resulting seedlings exhibiting greater fresh weight and no signs of etiolation. In the acclimation phase, the RB spectrum increased phytochemicals, such as polyphenols, flavonoids, and reducing sugars, and boosted curcumin synthesis. Nevertheless, the antioxidant activity of the plants under the RB light spectrum did not intensify. We surmise that this may be due to the premature intraplant allocation of metabolites to alternative pathways (e.g., curcumin synthesis) under RB light.

2.
Molecules ; 27(17)2022 Aug 25.
Artículo en Inglés | MEDLINE | ID: mdl-36080235

RESUMEN

Microsorum scolopendia (MS), which grows on the Chilean island of Rapa Nui, is a medicinal fern used to treat several diseases. Despite being widely used, this fern has not been deeply investigated. The aim of this study was to perform a characterization of the polyphenolic and flavonoid identity, radical scavenging, antimicrobial, and anti-inflammatory properties of MS rhizome and leaf extracts (RAE and HAE). The compound identity was analyzed through the reversed-phase high-performance liquid chromatography (RP-HPLC) method coupled with mass spectrometry. The radical scavenging and anti-inflammatory activities were evaluated for DPPH, ORAC, ROS formation, and COX inhibition activity assay. The antimicrobial properties were evaluated using an infection model on Human Dermal Fibroblast adult (HDFa) cell lines incubated with Staphylococcus aureus and Staphylococcus epidermidis. The most abundant compounds were phenolic acids between 46% to 57% in rhizome and leaf extracts, respectively; followed by flavonoids such as protocatechic acid 4-O-glucoside, cirsimaritin, and isoxanthohumol, among others. MS extract inhibited and disaggregated the biofilm bacterial formed and showed an anti-inflammatory selective property against COX-2 enzyme. RAE generated a 64% reduction of ROS formation in the presence of S. aureus and 87.35% less ROS in the presence of S. epidermidis on HDFa cells. MS has great therapeutic potential and possesses several biological properties that should be evaluated.


Asunto(s)
Antiinfecciosos , Helechos , Polypodiaceae , Antibacterianos/farmacología , Antiinfecciosos/farmacología , Antiinflamatorios/farmacología , Antioxidantes/química , Antioxidantes/farmacología , Cromatografía Líquida de Alta Presión , Flavonoides/farmacología , Humanos , Extractos Vegetales/química , Extractos Vegetales/farmacología , Especies Reactivas de Oxígeno , Staphylococcus aureus
3.
Nutrients ; 12(2)2020 Jan 21.
Artículo en Inglés | MEDLINE | ID: mdl-31973190

RESUMEN

Ischemia-reperfusion (I/R) injury is an unresolved problem in liver resection and transplantation. The preexisting nutritional status related to the gut microbial profile might contribute to primary non-function after surgery. Clinical studies evaluating artificial nutrition in liver resection are limited. The optimal nutritional regimen to support regeneration has not yet been exactly defined. However, overnutrition and specific diet factors are crucial for the nonalcoholic or nonalcoholic steatohepatitis liver diseases. Gut-derived microbial products and the activation of innate immunity system and inflammatory response, leading to exacerbation of I/R injury or impaired regeneration after resection. This review summarizes the role of starvation, supplemented nutrition diet, nutritional status, and alterations in microbiota on hepatic I/R and regeneration. We discuss the most updated effects of nutritional interventions, their ability to alter microbiota, some of the controversies, and the suitability of these interventions as potential therapeutic strategies in hepatic resection and transplantation, overall highlighting the relevance of considering the extended criteria liver grafts in the translational liver surgery.


Asunto(s)
Dieta/métodos , Microbioma Gastrointestinal , Regeneración Hepática/fisiología , Hígado/fisiología , Daño por Reperfusión/prevención & control , Suplementos Dietéticos , Hepatectomía/efectos adversos , Humanos , Hígado/irrigación sanguínea , Hígado/cirugía , Estado Nutricional , Daño por Reperfusión/etiología , Daño por Reperfusión/microbiología
4.
Med Clin (Barc) ; 153(10): 380-386, 2019 11 29.
Artículo en Inglés, Español | MEDLINE | ID: mdl-31060878

RESUMEN

BACKGROUND AND OBJECTIVES: Influenza vaccine is recommended for patients with autoimmune inflammatory rheumatic diseases who receive biological therapy. To evaluate if biological therapy impairs immunization after seasonal influenza vaccine. MATERIAL AND METHODS: Patients with inflammatory arthopathies, psoriasis, inflammatory bowel disease or connective tissue diseases who were receiving or were going to initiate biological therapy were included and vaccinated during 2014-2015 influenza season. ELISA was used to measure influenza antigen A and B antibodies, before and after vaccination. Demographic parameters, diagnosis and kind of treatment were recorded and their influence on the final serological status against influenza was studied. RESULTS: 253 subjects were analyzed. After vaccination, 77% of participants presented detectable antibodies against antigen A and 50.6% of them had detectable antibodies against antigen B. Final seropositivity rate against antigen B antibodies increased from baseline (50.6% vs 43.5%, p<0.001). Anti-TNF drugs were associated with better response and rituximab with the worst (79.2% vs 55.0% for final seropositivity against antigen A, p=0.020). Vaccine response in the rituximab group tended to improve when the interval between the drug administration and the vaccination was at least 12 weeks (seropositivity rate 80.0% in those with the longer interval vs 25.0% in the other group, p=0.054). CONCLUSIONS: Among the patients on biological therapy vaccinated against influenza, anti-TNF therapy was identified as a predictive factor of final seropositivity. Rituximab presented a lower rate of final seropositivity, which could be increased with an accurate administration schedule.


Asunto(s)
Anticuerpos Monoclonales Humanizados/efectos adversos , Anticuerpos Antivirales/sangre , Terapia Biológica/efectos adversos , Virus de la Influenza A/inmunología , Virus de la Influenza B/inmunología , Vacunas contra la Influenza/inmunología , Adulto , Anciano , Anciano de 80 o más Años , Anticuerpos Monoclonales Humanizados/uso terapéutico , Enfermedades Autoinmunes/tratamiento farmacológico , Enfermedades Autoinmunes/inmunología , Biomarcadores/sangre , Enfermedades del Tejido Conjuntivo/tratamiento farmacológico , Enfermedades del Tejido Conjuntivo/inmunología , Ensayo de Inmunoadsorción Enzimática , Femenino , Estudios de Seguimiento , Humanos , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Enfermedades Inflamatorias del Intestino/inmunología , Masculino , Persona de Mediana Edad , Enfermedades Reumáticas/tratamiento farmacológico , Enfermedades Reumáticas/inmunología
5.
BMC Complement Altern Med ; 19(1): 39, 2019 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-30717730

RESUMEN

BACKGROUND: Alzheimer's disease (AD) and osteoporosis are progressive diseases that affect the elderly population. Both conditions are associated with fracture risk that is greater than twice that of the healthy population. Resveratrol and exercise are two treatments that have been linked with attenuation of age-related diseases, including the risk of bone fractures. In this study, we test the hypothesis that these treatments improve fracture resistance in a mouse model representative of the AD condition. METHODS: Three-month-old male 3xTg-AD mice were treated for 4 months with resveratrol or exercise or both combined, and compared with wild type mice. Exercise training was performed on a treadmill at 15 m/min for 45 min/day, 5 days/week. Resveratrol was given at 4 g/kg diet in the form of pellets. Three-point bending, cross-sectional geometric, and fluorescence analyses were conducted on tibias and compared by treatment group. RESULTS: Tibias of 3xTg mice exhibited signs of diminished bone quality and fracture under less force than age-matched wild type mice (P < 0.05). Treatment with both resveratrol and exercise improved indicators of fracture resistance and bone quality in AD mice to levels comparable to that of wild type mice (P < 0.05). CONCLUSIONS: The 3xTg mouse model of AD is at elevated risk for limb bone fracture compared to wild type controls. Treatment with resveratrol, exercise, or both in combination improves fracture resistance and cross-sectional geometric indicators of bone strength.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Prueba de Esfuerzo/efectos de los fármacos , Sustancias Protectoras/farmacología , Resveratrol/farmacología , Tibia/efectos de los fármacos , Animales , Modelos Animales de Enfermedad , Masculino , Ratones , Ratones Transgénicos , Tibia/fisiología , Fracturas de la Tibia/prevención & control , Soporte de Peso/fisiología
6.
Psicol. soc. (Online) ; 30: e159429, 2018.
Artículo en Portugués | LILACS | ID: biblio-955884

RESUMEN

RESUMO Este trabalho destaca o papel das metáforas no processo de objetivação de representações sociais, considerando-as noções-chave para a compreensão das teorias do senso comum. Hoje, com o surgimento contínuo de novos objetos sociais, as metáforas facilitam e economizam o tempo e o esforço cognitivo da pragmática comunicativa. A articulação proposta exemplifica-se a partir de pesquisa anterior, que utilizou a metodologia do Modelo da Estratégia Argumentativa (MEA) para a análise do discurso sobre o Estatuto da Criança e do Adolescente - ECA. Essa metodologia busca não só a estrutura do discurso, quer dizer os tipos de argumentos e sua força argumentativa, mas principalmente as intenções dos oradores, quando argumentam buscando persuadir um auditório específico. Os resultados evidenciaram metáforas usadas por diferentes grupos de agentes sociais, p. e, juiz como bombeiro, para organizar e justificar posturas e práxis relacionadas ao objeto ECA.


RESUMEN Este trabajo destaca el papel de las metáforas en el proceso de objetivación de representaciones sociales, considerándolas nociones básicas para la comprensión de las teorías del sentido común. Hoy en día, con el continuo surgimiento de nuevos objetivos sociales, las metáforas facilitan y economizan el tiempo y el esfuerzo cognitivo de la practica comunicativa. La articulación propuesta se ejemplifica a partir de la pesquisa anterior que utilizó la metodología del Modelo de Estrategia Argumentativa (MEA) para el análisis del discurso sobre el Estatuto de los Niños (Crianças) y Adolescentes - ECA. Esa metodología busca no solo la estructura del discurso, o sea los tipos de argumentos y su fuerza argumentativa, sino principalmente las intenciones de los oradores, cuando argumentan buscando persuadir a un auditorio específico. Los resultados ponen en evidencia las metáforas utilizadas por diferentes grupos de agentes sociales, por ejemplo, juez por bombero, para organizar y justificar actitudes y praxis


ABSTRACT This paper highlights the role of metaphors within the process of objectification of social representations, taking in account the key notions for understanding the folk theories. Nowadays, the continuous birth of new social objects the metaphors facilitate and economize time and cognitive effort of communicative pragmatics. Previous research utilized the Model of Strategy Argumentative (MSA) as a methodological way to analyze the discourse about the Child and Adolescent Law (CAL). This methodology seeks not only the structure of discourse, the types and strength of arguments, but also and mainly the speaker intention while arguing trying to persuade a specific auditory. Findings showed that different groups of social agents used metaphors like judge as fireman, to organize, orient and justify their posture and praxis related to the object CAL.


Asunto(s)
Humanos , Masculino , Femenino , Defensa del Niño , Metáfora , Discurso
7.
Clin Sci (Lond) ; 131(8): 733-746, 2017 Apr 25.
Artículo en Inglés | MEDLINE | ID: mdl-28246131

RESUMEN

In the present study, we examined the effects of cortisol on steatotic and non-steatotic liver grafts from brain-dead donors and characterized the underlying mechanisms involved. Non-steatotic liver grafts showed reduced cortisol and increased cortisone levels in association with up-regulation of enzymes that inactivate cortisol. Conversely, steatotic liver grafts exhibited increased cortisol and reduced cortisone levels. The enzymes involved in cortisol generation were overexpressed, and those involved in cortisol inactivation or clearance were down-regulated in steatotic liver grafts. Exogenous administration of cortisol negatively affected hepatic damage and survival rate in non-steatotic liver transplantation (LT); however, cortisol treatment up-regulated the phosphoinositide 3-kinase (PI3K)-protein kinase C (PKC) pathway, resulting in protection against the deleterious effects of brain-dead donors on damage and inflammatory response in steatotic LT as well as in increased survival of recipients. The present study highlights the differences in the role of cortisol and hepatic mechanisms that regulate cortisol levels based on the type of liver. Our findings suggest that cortisol treatment is a feasible and highly protective strategy to reduce the adverse effects of brain-dead donor livers in order to ultimately improve liver graft quality in the presence of steatosis, whereas cortisol treatment would not be recommended for non-steatotic liver grafts.


Asunto(s)
Hígado Graso/metabolismo , Hidrocortisona/uso terapéutico , Trasplante de Hígado/métodos , Hormona Adrenocorticotrópica/sangre , Animales , Glucemia/metabolismo , Muerte Encefálica , Cortisona/metabolismo , Evaluación Preclínica de Medicamentos/métodos , Hígado Graso/patología , Hidrocortisona/metabolismo , Hidrocortisona/farmacología , Hígado/metabolismo , Hígado/patología , Hepatopatías/etiología , Hepatopatías/patología , Hepatopatías/prevención & control , Trasplante de Hígado/efectos adversos , Fosfatidilinositol 3-Quinasa/biosíntesis , Proteína Quinasa C/biosíntesis , Ratas Zucker , Transducción de Señal/efectos de los fármacos , Tasa de Supervivencia , Síndrome de Respuesta Inflamatoria Sistémica/etiología , Síndrome de Respuesta Inflamatoria Sistémica/patología , Síndrome de Respuesta Inflamatoria Sistémica/prevención & control , Regulación hacia Arriba/efectos de los fármacos
8.
J Music Ther ; 51(1): 103-25, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25014925

RESUMEN

BACKGROUND: There is substantive literature reporting the importance and benefits of music and music therapy programs for older adults, and more specifically for those with dementia. However, few studies have focused on how these programs may contribute to quality of life. OBJECTIVES: Objectives for this exploratory study were: (a) to evaluate the potential effect of group music therapy program participation on the quality of life of older people with mild, moderate, and severe dementia living in a nursing home; (b) to identify and analyze changes in affect and participation that take place during music therapy sessions; and (c) to suggest recommendations and strategies for the design of future music therapy studies with people in various stages of dementias. METHODS: Sixteen participants (15 women; 1 man), with varying level of dementia participated in 12 weekly music therapy sessions. Based on Global Deterioration Scale (GDS) scores, phases of cognitive function were as follows: mild (n = 9; GDS 3-4), moderate (n = 5; GDS 5), and severe (n = 2; GDS 6-7). Data were collected using the GENCAT scale on Quality of Life. Sessions 1, 6, and 12 were also video recorded for post-hoc analysis of facial affect and participation behaviors. RESULTS: There was no significant difference in quality of life scores from pre to posttest (z = -0.824; p =0.410). However, there was a significant improvement in median subscale scores for Emotional Well-being (z = -2.176, p = 0.030), and significant worsening in median subscale scores for Interpersonal Relations (z =-2.074; p = 0.038) from pre to posttest. With regard to affect and participation, a sustained high level of participation was observed throughout the intervention program. Expressions of emotion remained low. CONCLUSIONS: Authors discuss implications of study findings to inform and improve future research in the areas of music therapy, quality of life, and individuals with dementia.


Asunto(s)
Afecto , Demencia/terapia , Musicoterapia/métodos , Psicoterapia de Grupo/métodos , Calidad de Vida/psicología , Índice de Severidad de la Enfermedad , Anciano , Cognición , Demencia/psicología , Femenino , Humanos , Relaciones Interpersonales , Masculino , Persona de Mediana Edad , Música , Satisfacción Personal , Resultado del Tratamiento
9.
Reumatol. clín. (Barc.) ; 6(supl.2): 1-5, sept. 2010. ilus, tab
Artículo en Español | IBECS | ID: ibc-148869

RESUMEN

En el síndrome de Sjögren primario (SSP) no se ha descrito hasta el momento una terapia eficaz para las manifestaciones glandulares a pesar del desarrollo de múltiples agentes orales y biológicos en los últimos años. Varios fármacos empleados como tratamiento de fondo en otras enfermedades se han probado empíricamente y, reconocida la hiperactividad de la célula B en el SSP, también los moduladores de estas se han ensayado en esta enfermedad. En este artículo se revisan los datos existentes sobre el uso de tratamientos modificadores de la enfermedad exclusivamente en el síndrome seco, encontrando que los ensayos publicados con fármacos antirreumáticos orales han mostrado resultados contradictorios y desalentadores, mientras que algunos tratamientos biológicos han resultado esperanzadores. Los problemas encontrados se centran sobre todo en la falta de una correcta y homogénea metodología en los diseños de los ensayos (AU)


No effective treatment has been documented for the glandular primary Sjögren syndrome (PSS) despite the development of oral and biologic agents that have significant activity against other autoimmune disorders. Some disease-modifying agents have been empirically evaluated for the treatment of PSS. Targeting B cells also seems very promising in SSP because of the B-cell hyperactivity recognized in this desease. This article reviews existing data on the use of disease-modifying therapy for glandular of SSP. To date, published studies and trials of oral DMARDs for the treatment of SSP have shown disappointing results. B-cell modulation is clearly a promising therapy for PSS. Many challenges in trial design and execution are evident from the studies reviewed (AU)


Asunto(s)
Humanos , Síndrome de Sjögren/tratamiento farmacológico , Terapia Biológica , Antirreumáticos/uso terapéutico , Síndrome de Sjögren/fisiopatología , Glándulas Exocrinas/fisiopatología , Corticoesteroides/uso terapéutico , Hidroxicloroquina/uso terapéutico , Linfocitos B
10.
Nutr Cancer ; 59(1): 14-20, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17927497

RESUMEN

Under the common denomination of Systemic Immune-Metabolic Syndrome (SIMS), we grouped many symptoms that share a similar pathophysiologic background. SIMS is the result of the dysfunctional interaction of tumor cells, stroma cells, and the immune system, leading to the release of cytokines and other systemic mediators such as eicosanoids. SIMS includes systemic syndromes such as paraneoplastic hemopathies, hypercalcemia, coagulopathies, fatigue, weakness, cachexia, chronic nausea, anorexia, and early satiety among others. Eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil can help in the management of persistent chronic inflammatory states, but treatment's compliance is generally poor. Preferentially, Cox-2 inhibition can create a favorable pattern of cytokines by decreasing the production of certain eicosanoids, although their role in SIMS is unknown. The aim of this study was to test the hypothesis that by modulating systemic inflammation through an eicosanoid-targeted approach, some of the symptoms of the SIMS could be controlled. We exclusively evaluated 12 patients for compliance. Patients were assigned 1 of the 4 treatment groups (15-, 12-, 9-, or 6-g dose, fractionated every 8 h). For patients assigned to 15 and 12 doses, the overall compliance was very poor and unsatisfactory for patients receiving the 9-g dose. The maximum tolerable dose was calculated to be around 2 capsules tid (6 g of fish oil per day). A second cohort of 22 patients with advanced lung cancer and SIMS were randomly assigned to receive either fish oil, 2 g tid, plus placebo capsules bid (n = 12) or fish oil, 2 g tid, plus celecoxib 200 mg bid (n = 10). All patients in both groups received oral food supplementation. After 6 wk of treatment, patients receiving fish oil + placebo or fish oil + celecoxib showed significantly more appetite, less fatigue, and lower C-reactive protein (C-RP) values than their respective baselines values (P < 0.02 for all the comparisons). Additionally, patients in the fish oil + celecoxib group also improved their body weight and muscle strength compared to baseline values (P < 0.02 for all the comparisons). Comparing both groups, patients receiving fish oil + celecoxib showed significantly lower C-RP levels (P = 0.005, t-test), higher muscle strength (P = 0.002, t-test) and body weight (P = 0.05, t-test) than patients receiving fish oil + placebo. The addition of celecoxib improved the control of the acute phase protein response, total body weight, and muscle strength. Additionally, the consistent nutritional support used in our patients could have helped to maximize the pharmacological effects of fish oil and/or celecoxib. This study shows that by modulating the eicosanoid metabolism using a combination of n-3 fatty acids and cyclooxygenase-2 inhibitor, some of the signs and symptoms associated with a SIMS could be ameliorated.


Asunto(s)
Caquexia/tratamiento farmacológico , Inhibidores de la Ciclooxigenasa 2/uso terapéutico , Ácidos Grasos Omega-3/uso terapéutico , Aceites de Pescado/química , Neoplasias Pulmonares/complicaciones , Pirazoles/uso terapéutico , Sulfonamidas/uso terapéutico , Adulto , Anciano , Anciano de 80 o más Años , Apetito/efectos de los fármacos , Proteína C-Reactiva/análisis , Celecoxib , Estudios de Cohortes , Suplementos Dietéticos , Ácidos Docosahexaenoicos/uso terapéutico , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Ácido Eicosapentaenoico/uso terapéutico , Fatiga/tratamiento farmacológico , Femenino , Humanos , Masculino , Dosis Máxima Tolerada , Persona de Mediana Edad , Fuerza Muscular/efectos de los fármacos , Cooperación del Paciente , Síndrome , Aumento de Peso/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA